Abstract 2835: Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming

Abstract Radiation Therapy (RT) is one of the most common treatments for patients with solid tumors, administered to over 50% of patients. Failure of tumor control following RT, however, is a significant clinical challenge. In the present study, we identify a suite of novel proteins as radiation-inducible surface proteins across a variety of cancers, including breast and non-small cell lung cancers. Specific proteins characterized act as enzymes which deplete metabolic substrates, thus altering both the tumor microenvironment (TME) as well as cell intrinsic function. Using cell-surface capture mass spectrometry, bulk-RNA sequencing, fluorescence spectrometry, and cytometry by time of flight (CyTOF), we comprehensively characterize our target upregulation following RT, both as a surface protein and the enzymatic consequence of perturbation. To increase induction of surface expression, we evaluated combinatorial strategies of RT with small molecules and other soluble factors. These combinations significantly increased expression in vitro in both mouse and human non-small cell lung cancer cell lines. Additionally, in vivo, tumor-targeted RT/combination treatment significantly upregulated our protein of interest on tumor cells, as well as on a subset of macrophages and fibroblasts. Functional investigation suggests these macrophages and fibroblasts may have an immunosuppressive role within the TME. Leveraging these findings, we developed directed therapies, including antibody-drug conjugates (ADCs) and antigen-specific chimeric antigen receptor (CAR) T cells, to ablate both tumor and immunosuppressive cells with increased levels of the target, providing a more conducive combinatorial therapy to control tumors. In conclusion, we have identified and characterized a radiation-inducible therapeutic target, providing framework for reprogramming the TME and improving treatment efficacy. Citation Format: Courtney M. Tamaki, Maxwell Foisey, Charlotte Chen, Nam Woo Cho, . Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2835.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-2835
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2835: Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming

Nam Woo Cho, Maxwell Gabriel Foisey, Courtney Tamaki
Cancer Research
Cancer Research and Treatments
article

Abstract 2835: Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming

Nam Woo Cho, Maxwell Gabriel Foisey, Courtney Tamaki
article en

Abstract

Abstract Radiation Therapy (RT) is one of the most common treatments for patients with solid tumors, administered to over 50% of patients. Failure of tumor control following RT, however, is a significant clinical challenge. In the present study, we identify a suite of novel proteins as radiation-inducible surface proteins across a variety of cancers, including breast and non-small cell lung cancers. Specific proteins characterized act as enzymes which deplete metabolic substrates, thus altering both the tumor microenvironment (TME) as well as cell intrinsic function. Using cell-surface capture mass spectrometry, bulk-RNA sequencing, fluorescence spectrometry, and cytometry by time of flight (CyTOF), we comprehensively characterize our target upregulation following RT, both as a surface protein and the enzymatic consequence of perturbation. To increase induction of surface expression, we evaluated combinatorial strategies of RT with small molecules and other soluble factors. These combinations significantly increased expression in vitro in both mouse and human non-small cell lung cancer cell lines. Additionally, in vivo, tumor-targeted RT/combination treatment significantly upregulated our protein of interest on tumor cells, as well as on a subset of macrophages and fibroblasts. Functional investigation suggests these macrophages and fibroblasts may have an immunosuppressive role within the TME. Leveraging these findings, we developed directed therapies, including antibody-drug conjugates (ADCs) and antigen-specific chimeric antigen receptor (CAR) T cells, to ablate both tumor and immunosuppressive cells with increased levels of the target, providing a more conducive combinatorial therapy to control tumors. In conclusion, we have identified and characterized a radiation-inducible therapeutic target, providing framework for reprogramming the TME and improving treatment efficacy. Citation Format: Courtney M. Tamaki, Maxwell Foisey, Charlotte Chen, Nam Woo Cho, . Leveraging radiation inducible surface protein targets for tumor microenvironment reprogramming [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2835.

Cancer ResearchVol. 86(7_Supplement)
University of California, San Francisco (US), University of San Francisco (US)
Good health and well-being
Openalex Percentile: Top 20%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.